Detail Information of Post-Translational Modifications
General Information of Drug Transporter (DT) | |||||
---|---|---|---|---|---|
DT ID | DTD0308 Transporter Info | ||||
Gene Name | SLC35F3 | ||||
Transporter Name | Putative thiamine transporter SLC35F3 | ||||
Gene ID | |||||
UniProt ID | |||||
Post-Translational Modification of This DT | |||||
Overview of SLC35F3 Modification Sites with Functional and Structural Information | |||||
Sequence |
MKKHSARVAP LSACNSPVLT LTKVEGEERP RDSPGPAEAQ APAGVEAGGR ASRRCWTCSR
AQLKKIFWGV AVVLCVCSSW AGSTQLAKLT FRKFDAPFTL TWFATNWNFL FFPLYYVGHV CKSTEKQSVK QRYRECCRFF GDNGLTLKVF FTKAAPFGVL WTLTNYLYLH AIKKINTTDV SVLFCCNKAF VFLLSWIVLR DRFMGVRIVA AILAIAGIVM MTYADGFHSH SVIGIALVVA SASMSALYKV LFKLLLGSAK FGEAALFLSI LGVFNILFIT CIPIILYFTK VEYWSSFDDI PWGNLCGFSV LLLTFNIVLN FGIAVTYPTL MSLGIVLSIP VNAVIDHYTS QIVFNGVRVI AIIIIGLGFL LLLLPEEWDV WLIKLLTRLK VRKKEEPAEG AADLSSGPQS KNRRARPSFA R |
||||
PTM type |
X-Phosphorylation
X-Ubiquitination
X: Amino Acid
|
Phosphorylation |
|||||
---|---|---|---|---|---|
Serine |
2 PTM Phenomena Related to This Residue | Click to Show/Hide the Full List | |||
PTM Phenomenon 1 |
Have the potential to influence SLC35F3 | [1] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Serine |
Modified Location |
258 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Phosphorylation at SLC35F3 Serine 258 has the potential to affect its expression or activity. | ||||
PTM Phenomenon 2 |
Have the potential to influence SLC35F3 | [2] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Serine |
Modified Location |
410 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Phosphorylation at SLC35F3 Serine 410 has the potential to affect its expression or activity. | ||||
Ubiquitination |
|||||
Alanine |
1 PTM Phenomena Related to This Residue | Click to Show/Hide the Full List | |||
PTM Phenomenon 1 |
Have the potential to influence SLC35F3 | [3] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Alanine |
Modified Location |
51 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Ubiquitination at SLC35F3 Alanine 51 has the potential to affect its expression or activity. | ||||
Phenylalanine |
1 PTM Phenomena Related to This Residue | Click to Show/Hide the Full List | |||
PTM Phenomenon 1 |
Have the potential to influence SLC35F3 | [4] , [5] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Phenylalanine |
Modified Location |
94 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Ubiquitination at SLC35F3 Phenylalanine 94 has the potential to affect its expression or activity. | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.